[1] 刘书中,张海英,张海龙.血清BMP-2检测在恶性肿瘤中的意义研究进展[J]. 中国实验诊断学,2015,19(6):1030-1034.
[2] HOGAN B L.Bone morphogenetic proteins in development[J]. Curr Opin Genet Dev,1996,6(4):432-438.
[3] WU J B,FU H Q,HUANG L Z,et al.Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism[J]. Cancer Gene Ther,2011,18(1):20-25.
[4] KANG M H,KIM J S,SEO J E,et al.BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway[J]. Exp Cell Res,2010,316(1):24-37.
[5] WANG S,GU M,JIANG H,et al.BMP-2 upregulates the AKT/mTOR pathway in breast cancer with microcalcification and indicates a poor prognosis[J]. Clin Transl Oncol,2020,22(8):1263-1271.
[6] PAGE C L,PUIFFE M L,MEUNIER L,et al.BMP-2 signaling in ovarian cancer and its association with poor prognosis[J]. J Ovarian Res,2009,2:4.
[7] KIM B R,OH S C,LEE D H,et al.BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation[J]. Tumour Biol,2015,36(12):9475-9486.
[8] LAI T H,FONG Y C,FU W M,et al.Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins[J]. Prostate,2008,68(12):1341-1353.
[9] 石福民,张宏伟,翟健,等.分化型甲状腺癌骨转移预测模型的构建[J]. 现代医学,2021,49(1):13-17.
[10] 青晓艳,徐义全.甲状腺未分化癌的分子机制研究[J]. 山东大学耳鼻喉眼学报,2020,34(3):26-31.
[11] FEI Z H,YAO C Y,YANG X L,et al.Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients[J]. Asian Pac J Cancer Prev,2013,14(4):5293-5299.
[12] LI C S,TIAN H,ZOU M,et al.Secreted phosphoprotein 24 kD (Spp24) inhibits growth of human pancreatic cancer cells caused by BMP-2[J]. Biochem Biophys Res Commun,2015,466(2):167-172.
[13] LAO L,SHEN J,TIAN H,et al.Secreted phosphoprotein 24 kD inhibits growth of human prostate cancer cells stimulated by BMP-2[J]. Anticancer Res,2016,36(11):5773-5780.
[14] 崔少千,范广宇,李建军,等.腺病毒介导的BMP-2基因转染兔骨髓基质干细胞及对其增殖、成骨分化的影响[J]. 东南大学学报(医学版),2009,28(1):22-26.
[15] 陈怡文,姜添铖,杨雯迪,等.肿瘤转移分子机制与治疗成像的研究进展[J]. 东南大学学报(医学版),2020,39(3):365-370.
[16] CLEMENT J H,RAIDA M,SANGER J,et al.Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells[J]. Int J Oncol,2005,27(2):401-407.
[17] GORDON K J,KIRKBRIDE K C,HOW T,et al.Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2[J]. Carcinogenesis,2009,30(2):238-248.
[18] ZHANG G,HUANG P,CHEN A,et al.How BMP-2 induces EMT and breast cancer stemness through Rb and CD44?[J] Cell Death Dis,2018,9(2):20.
[19] CHU H,LUO H,WANG H,et al.Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration[J]. Diagn Pathol,2014,19(9):123.
[20] FONG Y C,LI T M,WU C M,et al.BMP-2 increases migration of human chondrosarcoma cells via PI3K/Akt pathway[J]. J Cell Physiol,2008,217(3):846-855.
[21] PARK Y,KANG M H,SEO H Y,et al.Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression[J]. Med Oncol,2010,27(4):1192-1199.
[22] PARK Y,KIM J W,KIM D S,et al.The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer[J]. Cancer Res Treat,2008,40(3):127-132.
[23] KANG M H,OH S C,LEE H J,et al.Metastatic function of BMP-2 in gastric cancer cells:the role of PI3K/AKT,MAPK,the NF-κB pathway,and MMP-9 expression[J]. Exp Cell Res,2011,317(12):1746-1762. |